International Journal of Gynecological Cancer

Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer
pp. 183-191(9)
Authors: Bois, A. Du; Rochon, J.; Lamparter, C.; PFisterer, J.

Accuracy of frozen-section analysis in the diagnosis of ovarian tumors: a systematic quantitative review
pp. 192-202(11)
Authors: Medeiros, L.R.; Rosa, D.D.; Edelweiss, M.I.; Stein, A.T.; Bozzetti, M.C.; Zelmanowicz, A.; Pohlmann, P.R.; Meurer, L.; Carballo, M.T.

Understanding and treating depression among cancer patients
pp. 203-208(6)
Authors: Bailey, R.K.; Geyen, D.J.; Scott-Gurnell, K.; Hipolito, M.M.S.; Bailey, T.A.; Beal, J.M.

Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance
pp. 209-216(8)
Authors: See, H.T.; Freedman, R.S.; Kudelka, A.P.; Burke, T.W.; Gershenson, D.M.; Tangjitgamol, S.; Kavanagh,

Neoadjuvant chemotherapy in advanced ovarian cancer: a case-control study
pp. 217-223(7)
Authors: Loizzi, V.; Cormio, G.; Resta, L.; Rossi, C.A.; Di Gilio, A.R.; Cuccovillo, A.; Selvaggi, L.

Carboplatin hypersensitivity induced by low-dose paclitaxel/carboplatin in multiple platinum-treated patients with recurrent ovarian cancer
pp. 224-227(4)
Authors: Watanabe, Y.; Nakai, H.; Ueda, H.; Nozaki, K.; Hoshiai, H.

A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy
pp. 228-232(5)
Authors: ehral, S.; nal, M.M.; Özsezgn, S.; Sanci, M.; Atli, Ö.; Nayki, C.; Yildirim, Y.; Tinar, .

Intraperitoneal hyperthermic chemotherapy in ovarian cancer
pp. 233-239(7)
Authors: Gori, J.; CastañO, R.; Toziano, M.; Häbich, D.; Staringer, J.; De Quirós, D.G.B.; Felci, N.

Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens
pp. 240-245(6)
Authors: Uslu, R.; Sanli, U.A.; Dikmen, Y.; Karabulut, B.; Ozsaran, A.; Sezgin, C.; Muezzinoglu, G.G.; Omay, S.B.; Goker, E.

A novel early-stage orthotopic model for ovarian cancer in the Fischer 344 rat
pp. 246-254(9)
Authors: Sloan Stakleff, K.D; Rouse, A.G; Ryan, A.P; Haller, N.A; Von Gruenigen, V.E.

Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival
pp. 255-260(6)
Authors: Raspollini, M.R.; Amunni, G.; Villanucci, A.; Boddi, V.; Taddei, G.L.

Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization
pp. 261-266(6)
Authors: Fishman, A.; Shalom-Paz, E.; Fejgin, M.; Gaber, E.; Altaras, M.; Amiel, A.

Information given to women invited for cervical screening: results of two postal surveys seven years apart
pp. 267-272(6)
Authors: Duggal, H.V.; Olowokure, B.; Caswell, M.; Wardle, S.A.

Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer
pp. 273-277(5)
Authors: Lin, Y.S.; Tzeng, C.C.; Huang, K.F.; Kang, C.Y.; Chia, C.C.; Hsieh, J.F.

Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment
pp. 278-284(7)
Authors: Lindel, K.; Burri, P.; Studer, H.U.; Altermatt, H.J.; Greiner, R.H.; Gruber,

Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levels
pp. 285-291(7)
Authors: Münstedt, K.; Johnson, P.; Bohlmann, M.K.; Zygmunt, M.; von Georgi, R.; Vahrson, H.

Evaluation of cytologic screening results of the cervix
pp. 292-294(3)
Authors: Yalti, S.; Gürbüz, B.; BilgiÇ, R.; Çakar, Y.; Eren, S.

Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases
pp. 295-300(6)
Authors: Tsunoda, S.; Jobo, T.; Arai, M.; Imai, M.; KAnai, T.; Tamura, T.; Watanabe, J.; Obokata, A.; Kuramoto, H.

Antiproliferative activity and toxicity of 2-methoxyestradiol in cervical cancer xenograft mice
pp. 301-307(7)
Authors: Li, L.; Da, J.; Landström, M.; Ulmsten, U.; Fu, X.

Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer
pp. 308-311(4)
Authors: Ercoli, A.; Ferrandina, G.; Genuardi, M.; Zannoni, G.F.; Cicchillitti, L.; Raspaglio, G.; Carrara, S.; Mancuso, S.; Scambia, G.

Epstein–Barr virus plays little role in cervical carcinogenesis in Korean women
pp. 312-318(7)
Authors: Seo, S.S.; Kim, W.H.; Song, Y.S.; Kim, S.H.; Kim, J.W.; Park, N.H.; Kang, S.B.; Lee, H.P.

Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer
pp. 319-324(6)
Authors: Obermair, A.; Manolitsas, T.P.; Leung, Y.; Hammond, I.G.; McCartney, A.J.

Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy
pp. 325-328(4)
Authors: Machtinger, R.; Korach, J.; Padoa, A.; Fridman, E.; Zolti, M.; Segal, J.; Yefet, Y.; Goldenberg, M.; Ben-baruch, G.

Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma
pp. 329-336(8)
Authors: Arita, S.; Kikkawa, F.; Kajiyama, H.; Shibata, K.; Kawai, M.; Mizuno, K.; Nagasaka, T.; Ino, K.; Nomura, S.

Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas
pp. 337-342(6)
Authors: Kir, G.; Cetiner, H.; Karateke, A.; Gurbuz, A.; Bulbul, D.

Human telomerase RNA as endogenous control in endometrial tissue
pp. 343-348(6)
Authors: Paul-Samojedny, M.; Witek, A.; Samojedny, A.; Witkowska, A.; Wilczok, T.

Differential regulation of protein kinase C activity by modulating factors and Euonymus alatus (Thunb.) Sieb in human myometrial and uterine leiomyomal smooth muscle cells
pp. 349-358(10)
Authors: Lee, T.-K.; Lee, J.-Y.; Kim, D.-I.; Lee, Y.-C.; Kim, C.-H.

Steppe by steppe: gynecological oncology on the Mongolian plains
pp. 359-360(2)
Author: Elit, L.

Extrauterine müllerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature
pp. 361-365(5)
Authors: Chang, H.-Y.; Changchien, C.-C.; Chen, H.-H.; Lin, H.; Huang, C.-C.

Villoglandular adenocarcinoma of the cervix recurrent in an episiotomy scar: a case report in a 32-year-old female
pp. 366-371(6)
Authors: Heron, D.E.; Axtel, A.; Gerszten, K.; Amortegui, A.; Kelley, J.; Comerci, J.; Edwards, R.P

A case with multiple gynecological malignancies
pp. 372-376(5)
Authors: Goker, B.o.; Bese, T.; Ilvan, S.; Yilmaz, E.; Demirkiran, F.

Umbilical metastasis (Sister Joseph's nodule) as a first sign of a disseminated ovarian carcinoma: comparative immunohistochemical analysis of primary tumor and its metastases
pp. 377-381(5)
Authors: Brasanac, D.; Boricic, I.; Todorovic, V.; Basta-Jovanovic, G.

Immature ovarian teratoma in a young girl: very short course and lethal outcome. A case report
pp. 382-384(3)
Authors: Terzic, M.; Dokic, M.; Stimec,

Placental site trophoblastic tumor presenting as subaponeurotic metastasis
pp. 385-388(4)
Authors: Aoki, Y.; Kase, H.; Kashima, K.; Yahata, T.; Tanaka, K.

A systematic nerve-sparing radical hysterectomy technique in invasive cervical cancer for preserving postsurgical bladder function
pp. 389-397(9)
Authors: Sakuragi, N.; Todo, Y.; Kudo, M.; Yamamoto, R.; Sato, T.

Surgeon's Corner: 1
pp. 398-399(2)

Early molecular changes in endometrial cancer
pp. 399-400(2)
Author: Ellenson, L. H.

Loss of cables is associated with development of endometrial hyperplasia and cancer
pp. 400-400(1)
Authors: Rueda, B.R.; Zukerberg, L.R.

Endometrial cancer in women with HNPCC
pp. 400-401(2)
Author: Lu, K.

Atypical endometrial hyperplasia: A tough call
pp. 401-401(1)
Author: Trimble, C. L.

Controversies in the management of atypical hyperplasia: Conservative management vs. simple hysterectomy
pp. 401-402(2)
Author: Curtin, J. P.

Predictors of poor prognosis in endometrial cancer
pp. 402-402(1)
Authors: Mariani, A.; Dowdy, S.; Podratz, K.C.

MSI in endometrial cancer: Prevalence and clinical applications
pp. 402-403(2)
Author: Goodfellow, P.J.

Role of gene expression profiling in distinguishing biologically and clinically distinct subclasses of endometrial carcinoma
pp. 403-403(1)
Author: Boyd, J.

Diagnostic challenges in pathology
pp. 403-405(3)
Author: Silva E.G.

CpG Island methylation patterns in various histotypes of endometrial cancer
pp. 405-405(1)
Authors: Broaddus, R.R.; Xie, S.-S.; Ramondetta, L.; Issa, J.-P.; Loose, D.

Novel strategies for the management of uterine malignant mixed mullerian tumors
pp. 405-405(1)
Author: Ramondetta, L.M.

What is the correct management of stage i UPSC?
pp. 405-406(2)
Author: Huh, W.K.

Advances in the management of advanced and recurrent uterine papillary serous carcinoma
pp. 406-406(1)
Authors: Slomovitz, B.M.; Wolf, J.; Ramondetta, L.M.; Burke, T.W.; Lu, K.H.

Is lymphadenectomy required for all patients with endometrial cancer?
pp. 406-407(2)
Author: Kilgore, L.C.

Laparoscopically assisted surgical staging for endometrial cancer
pp. 407-407(1)
Author: Barakat, R.R.

Updates in chemotherapy in the treatment of advanced and recurrent endometrial cancer
pp. 407-408(2)
Author: McMeekin, D.S.

The role of radiation treatment in intermediate risk endometrial cancer—pro
pp. 408-409(2)
Author: Eifel, Patricia J.

Role of radiation treatment in intermediate risk endometrial cancer—con
pp. 409-409(1)
Author: Burke, T.W.

Tyrosine kinase inhibitors in endometrial cancer
pp. 409-411(3)
Authors: Leslie, K.K.; Laidler, L.; Albitar, L.; Davies, S.; Holmes, A.; Nguyen, T.; Bolnick, J.; Dai, D.

Novel biologic therapies for the treatment of endometrial cancer
pp. 411-411(1)
Authors: Wolf, J.; Slomovitz, B.M.